基于植物生产两种针对霍乱弧菌脂多糖免疫显性表位的嵌合单克隆IgG抗体。
Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
作者信息
Levinson Kara J, Giffen Samantha R, Pauly Michael H, Kim Do H, Bohorov Ognian, Bohorova Natasha, Whaley Kevin J, Zeitlin Larry, Mantis Nicholas J
机构信息
Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States; Department of Biomedical Sciences, University at Albany, Albany, NY 12208, United States.
Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, United States.
出版信息
J Immunol Methods. 2015 Jul;422:111-7. doi: 10.1016/j.jim.2015.04.001. Epub 2015 Apr 9.
Abstract
We have produced and characterized two chimeric human IgG1 monoclonal antibodies that bind different immunodominant epitopes on Vibrio cholerae lipopolysaccharide (LPS). MAb 2D6 IgG1 recognizes Ogawa O-polysaccharide antigen, while mAb ZAC-3 IgG1 recognizes core/lipid A moiety of Ogawa and Inaba LPS. Both antibodies were expressed using a Nicotiana benthamiana-based rapid antibody-manufacturing platform (RAMP) and evaluated in vitro for activities associated with immunity to V. cholerae, including vibriocidal activity, bacterial agglutination and motility arrest.
摘要
我们制备并鉴定了两种嵌合人IgG1单克隆抗体，它们可结合霍乱弧菌脂多糖（LPS）上不同的免疫显性表位。单克隆抗体2D6 IgG1识别小川型O-多糖抗原，而单克隆抗体ZAC-3 IgG1识别小川型和稻叶型LPS的核心/脂质A部分。两种抗体均使用基于本氏烟草的快速抗体制备平台（RAMP）表达，并在体外评估了与霍乱弧菌免疫相关的活性，包括杀弧菌活性、细菌凝集和运动抑制。
相似文献
1
Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
J Immunol Methods. 2015 Jul;422:111-7. doi: 10.1016/j.jim.2015.04.001. Epub 2015 Apr 9.
2
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.
J Biol Chem. 1998 Jan 30;273(5):2777-83. doi: 10.1074/jbc.273.5.2777.
3
Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
Microbiology (Reading). 1999 Sep;145 ( Pt 9):2477-2484. doi: 10.1099/00221287-145-9-2477.
4
Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of O-Specific Polysaccharide-Specific Monoclonal Antibodies.
mBio. 2021 Apr 20;12(2):e03679-20. doi: 10.1128/mBio.03679-20.
5
A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
Vaccine. 2016 Nov 21;34(48):5833-5836. doi: 10.1016/j.vaccine.2016.10.023. Epub 2016 Oct 20.
6
Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.
Microbiology (Reading). 2009 Jul;155(Pt 7):2353-2364. doi: 10.1099/mic.0.025726-0. Epub 2009 Apr 23.
7
Generation and Characterization of Monoclonal Antibodies to the Ogawa Lipopolysaccharide of O1 from Phage-Displayed Human Synthetic Fab Library.
J Microbiol Biotechnol. 2020 Nov 28;30(11):1760-1768. doi: 10.4014/jmb.2005.05046.
8
Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
Infect Immun. 2015 Apr;83(4):1674-83. doi: 10.1128/IAI.02856-14. Epub 2015 Feb 9.
9
Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
mBio. 2016 Dec 20;7(6):e02021-16. doi: 10.1128/mBio.02021-16.
10
Detection of Vibrio cholerae with monoclonal antibodies specific for serovar O1 lipopolysaccharide.
J Clin Microbiol. 1988 Sep;26(9):1801-9. doi: 10.1128/jcm.26.9.1801-1809.1988.
引用本文的文献
1
Passive Immunity to O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk.
Pathog Immun. 2020 May 8;5(1):89-116. doi: 10.20411/pai.v5i1.370. eCollection 2020.
2
Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of O-Specific Polysaccharide-Specific Monoclonal Antibodies.
mBio. 2021 Apr 20;12(2):e03679-20. doi: 10.1128/mBio.03679-20.
3
Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
Pathog Dis. 2020 Jun 1;78(4). doi: 10.1093/femspd/ftaa029.
4
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.
PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0007803. doi: 10.1371/journal.pntd.0007803. eCollection 2020 Mar.
5
Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.
PLoS One. 2018 Jan 2;13(1):e0190026. doi: 10.1371/journal.pone.0190026. eCollection 2018.
6
Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-30.
Antimicrob Agents Chemother. 2017 Oct 24;61(11). doi: 10.1128/AAC.01428-17. Print 2017 Nov.
7
A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.
Vaccine. 2016 Nov 21;34(48):5833-5836. doi: 10.1016/j.vaccine.2016.10.023. Epub 2016 Oct 20.
本文引用的文献
1
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.
Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29.
2
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
PLoS Negl Trop Dis. 2014 May 1;8(5):e2828. doi: 10.1371/journal.pntd.0002828. eCollection 2014 May.
3
Chimeric plantibody passively protects mice against aerosolized ricin challenge.
Clin Vaccine Immunol. 2014 May;21(5):777-82. doi: 10.1128/CVI.00003-14. Epub 2014 Feb 26.
4
Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2683. doi: 10.1371/journal.pntd.0002683. eCollection 2014 Feb.
5
Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti.
mBio. 2013 Jul 2;4(4):e00398-13. doi: 10.1128/mBio.00398-13.
6
Insights from natural infection-derived immunity to cholera instruct vaccine efforts.
Clin Vaccine Immunol. 2012 Nov;19(11):1707-11. doi: 10.1128/CVI.00543-12. Epub 2012 Sep 19.
7
Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.
Clin Vaccine Immunol. 2012 Nov;19(11):1712-21. doi: 10.1128/CVI.00321-12. Epub 2012 Sep 19.
8
Cholera.
Lancet. 2012 Jun 30;379(9835):2466-2476. doi: 10.1016/S0140-6736(12)60436-X.
9
Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit.
Vaccine. 2012 Feb 8;30(7):1239-43. doi: 10.1016/j.vaccine.2011.12.058. Epub 2011 Dec 22.
10
Vibriocidal assays to determine the antibody titer of patient sera samples.
Curr Protoc Microbiol. 2011 Nov;Chapter 6:Unit6A.3. doi: 10.1002/9780471729259.mc06a03s23.
Zotero 插件